SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-23-003694
Filing Date
2023-03-09
Accepted
2023-03-09 15:07:46
Documents
1
Period of Report
2023-03-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-59527.html 4  
1 PRIMARY DOCUMENT marketforms-59527.xml 4 4201
  Complete submission text file 0001214659-23-003694.txt   5605
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Marshall Ken W. (Reporting) CIK: 0001740092 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 23719387